In ₹ Crore except Per Share Latest Annual | NUVOCO FY26 | ULTRACEMCO FY26 | AMBUJACEM FY26 | DALBHARAT FY26 | Peer Median | |
|---|---|---|---|---|---|---|
| Valuation — at last close | ||||||
| P/E | 32.78× | 39.45× | ◆ 20.70× | 28.86× | 28.86× +14% | |
| P/B | ◆ 1.15× | 4.00× | 1.36× | 1.84× | 1.84× -37% | |
| EV/EBITDA | ◆ 8.75× | 20.06× | 14.86× | 11.27× | 14.86× -41% | |
| Market Cap | ₹11,790 Cr | ₹3.23L Cr | ₹97,982 Cr | ₹33,298 Cr | ₹97,982 Cr -88% | |
| Growth | ||||||
| Revenue CAGR 3Y | 2.31% | ◆ 11.86% | 7.03% | 3.02% | 7.03% -67% | |
| Revenue CAGR 5Y | 8.65% | ◆ 14.63% | 7.02% | 7.07% | 7.07% +22% | |
| Net Income CAGR 3Y | ◆ 183.08% | 17.30% | 5.96% | 2.35% | 5.96% +2972% | |
| Revenue YoY (latest Q) | 8.91% | ◆ 15.85% | -7.67% | 6.99% | 6.99% +27% | |
| Net Income YoY (latest Q) | ◆ 19.88% | 17.24% | -31.93% | -51.39% | -31.93% +162% | |
| Profitability | ||||||
| EBITDA Margin | 16.38% | 19.23% | 16.08% | ◆ 20.83% | 19.23% -15% | |
| Net Income Margin | 3.17% | 9.25% | ◆ 13.87% | 7.82% | 9.25% -66% | |
| Return on Common Equity | 3.51% | ◆ 10.12% | 6.58% | 6.28% | 6.58% -47% | |
| Return on Capital Employed | 6.49% | ◆ 11.51% | 3.88% | 6.27% | 6.27% +4% | |
| Return on Assets | 1.77% | 5.79% | ◆ 6.29% | 3.47% | 5.79% -69% | |
| Credit & Quality | ||||||
| Total Debt/Equity | 0.44× | 0.28× | ◆ 0.00× | 0.37× | 0.28× +57% | |
| Interest Coverage | 2.44× | 6.61× | ◆ 13.28× | 3.61× | 6.61× -63% | |
| Scale — latest FY | ||||||
| Revenue / Total Income | ₹11,338 Cr | ₹88,512 Cr | ₹40,656 Cr | ₹14,804 Cr | ₹40,656 Cr -72% | |
| Net Income | ₹360 Cr | ₹8,188 Cr | ₹5,637 Cr | ₹1,157 Cr | ₹5,637 Cr -94% | |
| Total Assets | ₹20,299 Cr | ₹1.41L Cr | ₹89,607 Cr | ₹33,312 Cr | ₹89,607 Cr -77% | |
| EPS | ₹10.07 | ₹277.62 | ₹19.15 | ₹60.73 | ₹60.73 -83% | |
| Book Value per Share | ₹286.39 | ₹2,738.99 | ₹290.66 | ₹953.84 | ₹953.84 -70% | |